MDS Analytical Technologies Introduces New Systems for Genomics Research
14 Maggio 2008 - 2:00PM
PR Newswire (US)
New Axon GenePix(R) microarray scanners and Arcturus(R) Laser
Capture Microdissection instrument improve research speed and
precision SUNNYVALE, CA, May 14 /PRNewswire-FirstCall/ -- MDS
Analytical Technologies, a leader in innovative solutions for drug
discovery and life sciences research, announced today the release
of three new molecular biology instruments designed to advance
genomics and microgenomics discoveries for life sciences
researchers. These instruments provide scientists flexible and open
platforms to perform sensitive and specific molecular analysis in a
number of fields, including stem cell research, cancer research,
proteomics, drug discovery and many others. Two new microarray
scanners, the Axon GenePix(R) 4300A and the Axon GenePix(R) 4400A,
represent the latest in a long line of industry-leading microarray
detection and analysis systems from MDS Analytical Technologies.
These newest platforms improve the efficiency of research
experiments, reduce the cost per data point, and offer the broadest
applicability in the microarray industry. For researchers using
laser capture microdissection (LCM), a method for isolating cells
under a microscope, the new, next-generation ArcturusXT(TM)
instrument uses the latest advances in microscope technology by
employing the Nikon Eclipse Ti-E inverted research microscope as
its base. This new technology improves speed, precision and
flexibility during the microdissection process - shortening the
length of time required for experiments and expanding application
potential through an increased range of available options. "These
new products continue our tradition of innovation and excellence,
offering reliability, flexibility, and high performance solutions
for life sciences researchers," commented Dr. Andy Boorn, president
of MDS Analytical Technologies. "The Axon GenePix 4300A and 4400A
scanners provide customers with the ability to run the most
advanced microarray applications in the industry, which keeps them
at the forefront of this technology field. The new ArcturusXT
system gives us a solid platform upon which to offer increasingly
beneficial features to researchers who use our LCM technology."
About MDS Analytical Technologies MDS Analytical Technologies is a
newly established MDS Inc. business unit and is a world-class
organization comprised of two main lines of business. The Sciex
product portfolio offers proven market leadership in mass
spectrometry through its joint ventures with two of the world's
leading analytical instrumentation and life sciences companies,
Applied Biosystems, a business of the Applera Corporations and
PerkinElmer Inc. Molecular Devices' product portfolio is the gold
standard in high-performance bioanalytical measurement systems that
accelerate and improve drug discovery and other life sciences
research. Find out more at http://www.moleculardevices.com/ or
http://www.mdssciex.com/. About MDS Inc. MDS Inc. (TSX: MDS; NYSE:
MDZ) is a global life sciences company that provides market-leading
products and services that our customers need for the development
of drugs and diagnosis and treatment of disease. We are a leading
global provider of pharmaceutical contract research, medical
isotopes for molecular imaging, radiotherapeutics, and analytical
instruments. MDS, Inc. has more than 5,500 highly skilled people in
29 countries. Find out more at http://www.mdsinc.com/ or by calling
1-888-MDS-7222, 24 hours a day. Note to Editors: Click here for a
detailed Product Fact Sheet on the Axon GenePix(R) 4300A, Axon
GenePix(R) 4400A and the ArcturisXT(TM). DATASOURCE: MDS Analytical
Technologies CONTACT: Media: Cheri Salazar, Director, Global
Marketing Communications, Molecular Devices, now part of MDS
Analytical Technologies, (408) 548-6316, ; Investors: Kim Lee,
Senior Director, Investor Relations, MDS Inc., (416) 213-4721,
Copyright